EP1104486A4 - Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons - Google Patents

Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons

Info

Publication number
EP1104486A4
EP1104486A4 EP99935685A EP99935685A EP1104486A4 EP 1104486 A4 EP1104486 A4 EP 1104486A4 EP 99935685 A EP99935685 A EP 99935685A EP 99935685 A EP99935685 A EP 99935685A EP 1104486 A4 EP1104486 A4 EP 1104486A4
Authority
EP
European Patent Office
Prior art keywords
diagnosing
imaging
monitoring
lung cancer
new method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99935685A
Other languages
German (de)
English (en)
Other versions
EP1104486A1 (fr
Inventor
Fei Yang
Yongming Sun
Herve Recipon
Roberto A Macina
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diadexus Inc
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Publication of EP1104486A1 publication Critical patent/EP1104486A1/fr
Publication of EP1104486A4 publication Critical patent/EP1104486A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5752—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the lungs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP99935685A 1998-08-04 1999-07-19 Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons Withdrawn EP1104486A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9523398P 1998-08-04 1998-08-04
US95233P 1998-08-04
PCT/US1999/016247 WO2000008206A1 (fr) 1998-08-04 1999-07-19 Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons

Publications (2)

Publication Number Publication Date
EP1104486A1 EP1104486A1 (fr) 2001-06-06
EP1104486A4 true EP1104486A4 (fr) 2002-07-17

Family

ID=22250833

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99935685A Withdrawn EP1104486A4 (fr) 1998-08-04 1999-07-19 Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons

Country Status (4)

Country Link
EP (1) EP1104486A4 (fr)
JP (1) JP3524061B2 (fr)
CA (1) CA2347656A1 (fr)
WO (1) WO2000008206A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6869592B1 (en) 1998-08-04 2005-03-22 Diadexus, Inc. Method and antibody for imaging lung cancer
US20030017468A1 (en) * 2000-08-28 2003-01-23 Sei-Yu Chen Compositions and methods relating to lung specific genes
JP2004520821A (ja) * 2000-10-26 2004-07-15 ディアデクサス インコーポレーテッド 肺特異的遺伝子およびタンパク質に関する組成物および方法
US20020160388A1 (en) * 2000-11-20 2002-10-31 Roberto Macina Compositions and methods relating to lung specific genes and proteins
JP2004520831A (ja) * 2000-11-20 2004-07-15 ディアデクサス インコーポレーテッド 肺特異的遺伝子およびタンパク質に関する組成物および方法
WO2002068633A2 (fr) * 2000-11-22 2002-09-06 Diadexus, Inc. Compositions et procedes concernant des genes et proteines specifiques aux poumons
DE10254601A1 (de) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
EP1790664A1 (fr) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
WO2013167153A1 (fr) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Anticorps utiles dans le diagnostic du cancer
WO2014075788A1 (fr) 2012-11-13 2014-05-22 Biontech Ag Agents de traitement de maladies cancéreuses exprimant claudine
GB2630774A (en) * 2023-06-07 2024-12-11 Curenetics Ltd Lung cancer biomarkers

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0695760A1 (fr) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Marqueur tumorale pour détecter le cancer du poumon
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
WO1998020143A1 (fr) * 1996-11-05 1998-05-14 Abbott Laboratories Reactifs et procedes pour le depistage de maladies pulmonaires
WO1998056951A1 (fr) * 1997-06-11 1998-12-17 Abbott Laboratories Reactifs et procedes utiles dans la detection de maladies pulmonaires
WO1999060160A1 (fr) * 1998-05-21 1999-11-25 Diadexus Llc Technique de diagnostic, de suivi et de stadification du cancer du poumon

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP0695760A1 (fr) * 1994-08-05 1996-02-07 F. Hoffmann-La Roche Ag Marqueur tumorale pour détecter le cancer du poumon
WO1998020143A1 (fr) * 1996-11-05 1998-05-14 Abbott Laboratories Reactifs et procedes pour le depistage de maladies pulmonaires
WO1998056951A1 (fr) * 1997-06-11 1998-12-17 Abbott Laboratories Reactifs et procedes utiles dans la detection de maladies pulmonaires
WO1999060160A1 (fr) * 1998-05-21 1999-11-25 Diadexus Llc Technique de diagnostic, de suivi et de stadification du cancer du poumon

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0008206A1 *

Also Published As

Publication number Publication date
JP3524061B2 (ja) 2004-04-26
JP2002522046A (ja) 2002-07-23
WO2000008206A1 (fr) 2000-02-17
EP1104486A1 (fr) 2001-06-06
CA2347656A1 (fr) 2000-02-17

Similar Documents

Publication Publication Date Title
EP1104486A4 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons
EP1090291A4 (fr) Procede de diagnostic precoce du cancer et de determination de pronostic correspondant
EP1455645A4 (fr) Procede et systeme de traitement d'electrocardiogrammes
FR2743642B1 (fr) Procede et appareil de diagnostic d'anomalies d'une installation
EP1107798A4 (fr) Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer du colon
EP1459243A4 (fr) Procede et systeme de compte-rendu d'analyse d'image
AU4407996A (en) Neural network method and apparatus for disease, injury and bodily condition screening or sensing
EP1049088A4 (fr) Systeme, dispositif et procede de traitement d'informations
EP1075219A4 (fr) Appareil et procede permettant de faciliter l'hemostase sur un trajet de biopsie
EP1309902A4 (fr) Systeme et procede de surveillance et de maitrise de distribution d'energie
EP1366460A4 (fr) Procede et systeme de detection de matieres fecales et d'ingesta pendant le traitement de viande et de volaille
EP0831924A4 (fr) Procede de traitement de l'asthme
EP1007535A4 (fr) Procedes et compositions de diagnostic et de traitement du cancer du sein
FR2837053B1 (fr) Procede et systeme d'imagerie bi ou multi-energetique
EP1056346A4 (fr) Procede et systeme d'epilage des animaux
EP1229834A4 (fr) Systeme et procede d'analyse quantitative et qualitative d'une main
FR2658617B1 (fr) Dispositif et procede d'identification et de quantification des hydrometeores par effet doppler.
FR2792430B1 (fr) Systeme et procede pour surveiller des appareils de formation d'image
EP1066408A4 (fr) Nouveau procede de detection et de surveillance d'un cancer endometrial ou uterin
EP0986340A4 (fr) Solution opaque aux rayons x permettant de visualiser l'anatomie dentaire et les zones presentant des etats pathologiques et des troubles iatrogenes, et procede d'utilisation de ladite solution
FR2835936B1 (fr) Procede et systeme d'analyse d'evenements de blocage logiciel
EP1001405A4 (fr) Procede de traitement d'image et affichage d'image
FR2774785B1 (fr) Procede de gestion d'application et appareil de traitement d'information utilisant le procede
EP0805972A4 (fr) Procede et appareil destines au diagnostic et a la detection d'anomalies et de morphologies cellulaires d'organismes vivants
FR2765591B1 (fr) Procede de diagnostic de la maladie d'alzheimer

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010305

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020604

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7G 01N 33/574 A, 7C 07K 16/30 B, 7C 12Q 1/68 B, 7A 61K 39/395 B

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: DIADEXUS, INC.

17Q First examination report despatched

Effective date: 20030630

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050924